PET Centres

ÚJV Řež, a. s. implements long-term projects for the construction, commissioning, and operation of PET centres in the Czech Republic. Our long-term and unique experience in this respective field allows us to primarily provide the following in constructing the PET centres:

• Advisory services
• Creation of comprehensive project documentation (civil and technology)
• Selection of suitable suppliers
• Acceptance tests
• Commissioning
• Obtaining the necessary authorisations and certificates for operation

The need for personnel training for PET centres became the basis for the project entitled "Comprehensive Personnel Training System in PET" which created a comprehensive thematic framework of knowledge and skills in the area of PET in close linkage to practical specialization. Specifically, we train the personnel in the following areas:

• Operation of cyclotron
• Manufacture of radiopharmaceuticals
• Quality control

Address:Nemocnice Na Homolce, Roentgenova 2,  č.p. 37, 150 30 Praha 5

• This is the first PET centre in the Czech Republic and was built in cooperation with the International Atomic Energy Agency (IAEA). IAEA approved the plan as a model project and pledged financial support. Through this cooperation, the construction of the first PET centre in the Czech Republic on the premises of the Na Homolce Hospital in Prague was commenced in November 1998. The PET Centre Prague was inaugurated in August 1999, and it was here that the first patient in the Czech Republic was examined using the PET method.
• The facility is equipped to manufacture the most commonly used PET radiopharmaceutical “Fludeoxyglukosa inj.” (commercial name of the product of ÚJV Řež, a. s.). This is a radiodiagnostics agent used by PET or PET/CT methods.

Address: Masarykův onkologický ústav, Žlutý kopec 7a, 656 53 Brno

• In order to make the Moravian regions independent of supplies of PET radiopharmaceuticals from Central Bohemia, a second PET centre was built within the Masaryk Memorial Cancer Institute in Brno in 2005. The construction started in April 2006. This construction was partially funded as part of the INOVACE II programme of the European Regional Development Fund (ERDF) as well as from the national budget of the Czech Republic. The PET Centre Brno commenced trial operation on 1 June 2007.
• The facility is equipped to manufacture the most commonly used PET radiopharmaceutical “Fludeoxyglukosa inj.” (commercial name of the product of ÚJV Řež, a. s.). This is a radiodiagnostics agent used by PET or PET/CT methods.

Address: ÚJV Řež, a. s., Hlavní 130, 250 68 Husinec - Řež

• The PET Center serves primarily for the R&D of new radiopharmaceuticals with ultra-short-living PET radionuclides.
• This project was awarded third place in the category of “Investor of 2010”.
  The prize for the highest innovation potential was awarded by CzechInvest in cooperation with the Ministry of Industry and Trade and the Association for Foreign Investment. The project was co-financed from the European Regional Development Fund (ERDF) and from the national budget of the Czech Republic under the POTENTIAL programme. The construction of a third floor of the R&D PET Centre Řež followed which, in cooperation with the health facility, plays a development-manufacturing-application role. The implementation of the second phase of the PET centre was supported by the European Regional Development Fund (ERDF) and the national budget of the Czech Republic under the OPPI programme (Operational Programme Enterprise and Innovation – Ministry of Industry and Trade), the Training Centre programme